Missouri’s first holiday season is expected to affect cannabis sales in the state.
Missouri’s Division of Cannabis Regulations stated that in the first 11 months since recreational cannabis sales began, Missouri dispensaries sales have reached $1.2 billion, and the state’s trade association estimates total sales to reach $1.3 billion for the year 2023 (1). A portion of the sales, $285 million, came from medical cannabis sales (1). Cannabis for recreational use was legalized in November 2022, with sales beginning in February 2023 (2). Medical cannabis was legalized in the state four years prior to that (2).
Sales are reportedly expected to level out throughout the year, but also increase during the holiday season (3).
Robin Goldstein, director of the Cannabis Economics Group at the University of California, explained to the Missouri Business Alert that licensed dispensaries have used tactics such as holiday packaging for products to compete with the illegal market (3). “That's their (dispensaries’) competitive advantage in the holiday season, nice looking stuff and nice looking products,” Goldstein said (3).
Goldstein also explained that cannabis sales are unpredictable from year to year (3). Sales in the state declined after the summer months and totaled about $112 million in November (3). “This isn't really a new industry,” stated Dan Freund, a co-owner of a dispensary in Farmington, Missouri (3). “We're still growing quite a bit, but the penny is not as shiny as it was a couple of years ago.” Still, some dispensary owners expect to see increases in sales during January, when individuals choose cannabis products instead of alcohol, and in April around the “cannabis holiday” of 4/20 (3).
See our coverage on cannabis sales in Missouri earlier this year.
Interested in the Missouri cannabis industry? Cannabis Science Conference Spring 2024 will take place on May 7-9 in Kansas City, Missouri! Learn more and register your spot here.
References
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.